Antman K - Search Results

1

Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.

Zalupski MM, Rankin C, Ryan JR, Lucas DR, Muler J, Lanier KS, Budd GT, Biermann JS, Meyers FJ, Antman K. Zalupski MM, et al. Among authors: antman k. Cancer. 2004 Feb 15;100(4):818-25. doi: 10.1002/cncr.20021. Cancer. 2004. PMID: 14770440 Free article. Clinical Trial.

2

High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.

Talbot SM, Rankin C, Taub RN, Balcerzak SP Jr, Bhoopalam N, Chapman RA, Baker LH, Middleman EL, Antman KH. Talbot SM, et al. Cancer. 2003 Jul 15;98(2):331-6. doi: 10.1002/cncr.11512. Cancer. 2003. PMID: 12872353 Free article. Clinical Trial.

3

Phase II trial of topotecan by continuous infusion in patients with advanced soft tissue sarcomas, a SWOG study. Southwest Oncology Group.

Budd GT, Rankin C, Hutchins LF, Wong L, Petruska PJ, Antman K; Southwest Oncology Group. Budd GT, et al. Among authors: antman k. Invest New Drugs. 2002 Feb;20(1):129-32. doi: 10.1023/a:1014461611890. Invest New Drugs. 2002. PMID: 12003189 Clinical Trial.

4

A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.

Antman K, Crowley J, Balcerzak SP, Kempf RA, Weiss RB, Clamon GH, Baker LH. Antman K, et al. Cancer. 1998 Apr 1;82(7):1288-95. Cancer. 1998. PMID: 9529020 Clinical Trial.

5

A phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinoma.

Tiersten AD, Nelsen C, Talbot S, Vahdat L, Fine R, Troxel A, Brafman L, Shriberg L, Antman K, Petrylak DP. Tiersten AD, et al. Among authors: antman k. Cancer. 2003 Feb 1;97(3):537-44. doi: 10.1002/cncr.11082. Cancer. 2003. PMID: 12548594 Free article. Clinical Trial.

6

Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group B.

Yogelzang NJ, Herndon JE 2nd, Cirrincione C, Harmon DC, Antman KH, Corson JM, Suzuki Y, Citron ML, Green MR. Yogelzang NJ, et al. Among authors: antman kh. Cancer. 1997 Jun 1;79(11):2237-42. doi: 10.1002/(sici)1097-0142(19970601)79:11<2237::aid-cncr23>3.0.co;2-w. Cancer. 1997. PMID: 9179072 Clinical Trial.

7

Long-term survival in peritoneal mesothelioma. The role of radiotherapy and combined modality treatment.

Lederman GS, Recht A, Herman T, Osteen R, Corson J, Antman KH. Lederman GS, et al. Among authors: antman kh. Cancer. 1987 Jun 1;59(11):1882-6. doi: 10.1002/1097-0142(19870601)59:11<1882::aid-cncr2820591107>3.0.co;2-0. Cancer. 1987. PMID: 3567851

8

Phase II trial of ifosfamide with mesna in previously treated metastatic sarcoma.

Antman KH, Montella D, Rosenbaum C, Schwen M. Antman KH, et al. Cancer Treat Rep. 1985 May;69(5):499-504. Cancer Treat Rep. 1985. PMID: 3924401

9

Survival of patients with localized high-grade soft tissue sarcoma with multimodality therapy. A matched control study.

Antman KH, Blum RH, Wilson RE, Corson JM, Greenberger JS, Amato DA, Canellos GP, Frei E 3rd. Antman KH, et al. Cancer. 1983 Feb 1;51(3):396-401. doi: 10.1002/1097-0142(19830201)51:3<396::aid-cncr2820510307>3.0.co;2-a. Cancer. 1983. PMID: 6821825

10

Doxorubicin, ifosfamide, and dacarbazine (AID) with mesna uroprotection for advanced untreated sarcoma: a phase I study.

Elias AD, Antman KH. Elias AD, et al. Among authors: antman kh. Cancer Treat Rep. 1986 Jul;70(7):827-33. Cancer Treat Rep. 1986. PMID: 3087617 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters